Extracellular vesicles as a drug delivery system: A systematic review of preclinical studies
Publication date
2021-08
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
During the past decades, extracellular vesicles (EVs) have emerged as an attractive drug delivery system. Here, we assess their pre-clinical applications, in the form of a systematic review. For each study published in the past decade, disease models, animal species, EV donor cell types, active pharmaceutical ingredients (APIs), EV surface modifications, API loading methods, EV size and charge, estimation of EV purity, presence of biodistribution studies and administration routes were quantitatively analyzed in a defined and reproducible way. We have interpreted the trends we observe over the past decade, to define the niches where to apply EVs for drug delivery in the future and to provide a basis for regulatory guidelines.
Keywords
Clinical trial, Drug delivery, Extracellular vesicles, Liposomes, Preclinical animal models, Systematic review, Taverne, Pharmaceutical Science, Review, Journal Article
Citation
Escudé Martinez de Castilla, P, Tong, L, Huang, C, Sofias, A M, Pastorin, G, Chen, X, Storm, G, Schiffelers, R M & Wang, J-W 2021, 'Extracellular vesicles as a drug delivery system : A systematic review of preclinical studies', Advanced Drug Delivery Reviews, vol. 175, 113801, pp. 1-39. https://doi.org/10.1016/j.addr.2021.05.011